Skip to main content
. Author manuscript; available in PMC: 2015 Jun 15.
Published in final edited form as: J Renin Angiotensin Aldosterone Syst. 2014 Aug 20;16(2):234–248. doi: 10.1177/1470320314543910

Figure 2.

Figure 2

Glomerulosclerosis is lower in focal segmental glomerulosclerosis (FSGS) mice given enalapril. Sirius red staining was used to detect glomerulosclerosis in (a) normal mice, (b) FSGS mice given water (untreated), (c) FSGS mice given hydralazine, (d) FSGS mice given enalapril. (e) shows the sclerosis index quantitating glomerulosclerosis. Compared to day 0 (baseline), glomerulosclerosis was higher in all three groups with FSGS at day 7 (*p < 0.05). At day 14, FSGS was higher in the untreated and hydralazine-treated mice (**P < 0.001 vs. day 7), but not in the enalapril-treated group.